B. Chetcha Chemegni

Erythrocyte Phenotyping in ABO, RH and Kell Blood Group Systems in the Donor and Recipient of Blood Products at the Yaounde University and Hospital Center

B. Chetcha Chemegni, A. Ndoumba, Jiatsa Bogning, E. Lontsi, C. Tayou Tagne & D. Mbanya · International Blood Research & Reviews · 2020

In order to prevent post transfusion alloimmunization, it is essential to give recipients compatible blood products. However in countries with limited income, blood grouping is limited to the ABO system and to the D antigen of the Rhesus system; however, there are other immunogen...

Open access Research Article 10.9734/ibrr/2020/v11i130123

Clinical and Biologic Outcomes Following the Administration of Hydroxyurea to Homozygote Sickle Cell Patients in Two Health Facilities of Yaounde

B. Chetcha Chemegni, A. V. Kouam Kaping, I. Ngosso Tetanyé, A. Bodieu Kenmegne, L. Kouemeni, G. Ngouefo, E. K. Ola Bamzok, Tetanye Ekoe & L. Kaptué Noche · Asian Hematology Research Journal · 2018

Sickle cell disease is the most frequent genetic disease worldwide with high mortality and morbidity rates. Several therapeutic medications have been put in place amongst which hydroxurea, an antineoplastic for which the clinical-biologic benefits for the patients have been estab...

Open access Research Article